Novavax (NVAX) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
The stock exceeded the S&P 500, which registered a loss of 0.25% for the day. Meanwhile, the Dow gained 0.77%, and the Nasdaq, a tech-heavy index, lost 0.79%. Heading into today, shares of the vaccine maker had lost 12.2% over the past month, lagging the Medical sector's gain of 0.03% and the S&P 500's gain of 3.59% in that time. The investment community will be closely monitoring the performance of Novavax in its forthcoming earnings report. In that report, analysts expect Novavax to post earnings of $1.13 per share. This would mark year-over-year growth of 94.83%. Alongside, our most recent consensus estimate is anticipating revenue of $429.83 million, indicating a 1.27% upward movement from the same quarter last year. For the full year, the Zacks Consensus Estimates project earnings of $0.49 per share and a revenue of $999.14 million, demonstrating changes of +109.06% and +1.57%, respectively, from the preceding year. It's also important for investors to be aware of any rec
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- New Covid Shots Recommended for Americans 6 Months and Older This Fall [The New York Times]The New York Times
- Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe [Yahoo! Finance]Yahoo! Finance
- Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/25/24 - Form 4
- 6/21/24 - Form 4
- 6/20/24 - Form 4
- NVAX's page on the SEC website